课题基金 / 基金详情

Development of a plant-grown subunit vaccine against respiratory syncytial virus

Development of a plant-grown subunit vaccine against respiratory syncytial virus
开发抗呼吸道合胞病毒的植物亚单位疫苗
批准号:
7802544
负责人:
Dennis Edward Buetow
金额:
$29.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-03-15 至 2012-02-29

项目摘要

项目成果

Dennis Edward Buetow的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):呼吸道合胞病毒(RSV)引起的疾病在世界范围内是一个重大的卫生保健负担。呼吸道合胞病毒感染了全世界发达国家和发展中国家的几乎所有儿童。再次感染很常见,因为自然感染不会产生持久的免疫力。此外,严重的呼吸道合胞病毒感染越来越多地发生在老年人中。尽管为生产有效的RSV疫苗进行了广泛的努力,但目前还没有疫苗可用。 开发一种廉价的食用植物性口服疫苗是控制RSV的一种创新方法。本研究首次将以植物为基础的口服疫苗的策略扩展到呼吸道病原体。即使植物疫苗不能获得持久免疫,在连续的RSV季节使用这种疫苗的成本也会相对较低。 我们以前已经证明,用表达RSV亚单位蛋白(即F蛋白)的转基因番茄水果口服免疫小鼠,可以诱导系统免疫反应。这项“原则证明”第一阶段研究将优化RSV-F蛋白在转基因番茄果实中的表达,并在RSV研究的两个常用模型--Balb/c小鼠和棉花大鼠中确定这种口服抗原蛋白抵御RSV攻击的能力。成功将验证我们针对RSV的番茄疫苗的进一步开发,并为第二阶段研究奠定基础。这样的疫苗肯定会有所不同,并对人类健康产生持久的影响。 公共卫生相关性:呼吸道合胞病毒引起的疾病是世界范围内严重的卫生保健负担,但没有疫苗可用。我们正在开发一种使用番茄植物来控制这种病毒的廉价疫苗。
英文摘要
DESCRIPTION (provided by applicant): Respiratory syncytial virus (RSV)-caused disease represents a significant health care burden worldwide. The RSV infects virtually all children throughout the world in both developed and developing countries. Re-infection is common because natural infection does not induce lasting immunity. Also, severe RSV infections are increasingly occurring among the elderly. In spite of wide-scale efforts to produce an effective vaccine against RSV, no vaccine is yet available. Development of an inexpensive edible plant-based oral vaccine is an innovative approach for the control of RSV. The present study extends the strategy of using a plant-based oral vaccine to a respiratory pathogen for the first time. Even if lasting immunity is not obtained with the plant-based vaccine, it would be relatively low in cost to use such a vaccine during successive RSV seasons. We have shown previously that oral immunization of mice with transgenic tomato fruit expressing an RSV- subunit protein, i.e., the F-protein, induces a systemic immune response. This "proof of principle" Phase I study will optimize the expression of the RSV-F protein in the transgenic tomato fruit and determine the capacity of this orally-given antigenic protein to protect against an RSV challenge in two commonly-used models for RSV studies, the Balb/c mouse and the cotton rat. Success will validate the further development of our tomato- based vaccine against RSV and set the stage for a Phase II study. Such a vaccine will definitely make a difference and have an enduring impact on human health. PUBLIC HEALTH RELEVANCE: Respiratory syncytial virus-caused disease is a significant health care burden worldwide, but no vaccine is available. We are developing an inexpensive vaccine using tomato plants to control this virus.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a plant-grown subunit vaccine against respiratory syncytial virus
  • 批准号:
    8044041
  • 项目类别:
  • 资助金额:
    $29.07万
  • 财政年份:
    2010
  • 负责人:
    Dennis Edward Buetow
  • 依托单位:
海外基金